Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tetralogy of Fallot | 29 | 2023 | 623 | 6.450 |
Why?
|
Heart Defects, Congenital | 66 | 2024 | 4584 | 5.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 15 | 2021 | 500 | 3.200 |
Why?
|
Fontan Procedure | 26 | 2023 | 778 | 2.780 |
Why?
|
Ventricular Dysfunction, Right | 15 | 2021 | 581 | 2.710 |
Why?
|
Pulmonary Valve | 9 | 2023 | 437 | 2.670 |
Why?
|
Ventricular Function, Right | 11 | 2021 | 591 | 1.860 |
Why?
|
Tachycardia, Ventricular | 8 | 2023 | 1273 | 1.610 |
Why?
|
Magnetic Resonance Imaging, Cine | 13 | 2018 | 964 | 1.540 |
Why?
|
Cardiac Surgical Procedures | 15 | 2023 | 3537 | 1.460 |
Why?
|
Heart Valve Prosthesis Implantation | 7 | 2021 | 1536 | 1.180 |
Why?
|
Pulmonary Valve Insufficiency | 6 | 2021 | 151 | 1.090 |
Why?
|
Cardiology | 12 | 2023 | 1668 | 1.030 |
Why?
|
Eisenmenger Complex | 2 | 2015 | 27 | 0.970 |
Why?
|
Ebstein Anomaly | 2 | 2023 | 97 | 0.960 |
Why?
|
Heart Failure | 12 | 2023 | 10900 | 0.950 |
Why?
|
Heart Valve Prosthesis | 7 | 2020 | 1488 | 0.910 |
Why?
|
Heart Ventricles | 13 | 2020 | 3821 | 0.910 |
Why?
|
Exercise Test | 10 | 2020 | 2074 | 0.820 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2023 | 349 | 0.820 |
Why?
|
Heart Valve Diseases | 4 | 2023 | 1073 | 0.750 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2023 | 488 | 0.740 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2017 | 2073 | 0.740 |
Why?
|
Patient Care Management | 2 | 2021 | 306 | 0.730 |
Why?
|
Venous Insufficiency | 2 | 2011 | 103 | 0.700 |
Why?
|
Hemodynamics | 13 | 2023 | 4199 | 0.680 |
Why?
|
Ventricular Remodeling | 6 | 2018 | 1224 | 0.660 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2020 | 183 | 0.660 |
Why?
|
Thromboembolism | 3 | 2023 | 986 | 0.660 |
Why?
|
Cardiac Imaging Techniques | 4 | 2015 | 269 | 0.650 |
Why?
|
Registries | 8 | 2023 | 8089 | 0.640 |
Why?
|
Ventricular Function, Left | 9 | 2021 | 3670 | 0.620 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2018 | 183 | 0.610 |
Why?
|
Scimitar Syndrome | 2 | 2014 | 31 | 0.610 |
Why?
|
Postoperative Complications | 13 | 2023 | 15295 | 0.610 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2013 | 859 | 0.600 |
Why?
|
Aortic Coarctation | 4 | 2016 | 281 | 0.590 |
Why?
|
Adult | 107 | 2024 | 214055 | 0.590 |
Why?
|
Blalock-Taussig Procedure | 1 | 2017 | 62 | 0.580 |
Why?
|
Magnetic Resonance Imaging | 21 | 2021 | 35421 | 0.540 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2017 | 364 | 0.530 |
Why?
|
Young Adult | 59 | 2023 | 56430 | 0.520 |
Why?
|
Child Nutrition Disorders | 1 | 2016 | 149 | 0.500 |
Why?
|
Humans | 173 | 2024 | 744343 | 0.490 |
Why?
|
Societies, Medical | 3 | 2015 | 3743 | 0.480 |
Why?
|
Pregnancy | 31 | 2023 | 29144 | 0.470 |
Why?
|
Myocardial Ischemia | 3 | 2020 | 2148 | 0.470 |
Why?
|
Clinical Protocols | 1 | 2019 | 1462 | 0.450 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 850 | 0.450 |
Why?
|
Echocardiography | 11 | 2020 | 5102 | 0.450 |
Why?
|
Adolescent | 57 | 2023 | 85781 | 0.440 |
Why?
|
Liver Cirrhosis | 7 | 2021 | 1863 | 0.410 |
Why?
|
Female | 115 | 2023 | 380194 | 0.400 |
Why?
|
Pulmonary Artery | 8 | 2019 | 1912 | 0.390 |
Why?
|
Anxiety | 2 | 2024 | 4297 | 0.380 |
Why?
|
Transposition of Great Vessels | 4 | 2018 | 588 | 0.380 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2018 | 1265 | 0.370 |
Why?
|
Arterio-Arterial Fistula | 1 | 2010 | 19 | 0.370 |
Why?
|
Blood Vessel Prosthesis | 1 | 2015 | 933 | 0.370 |
Why?
|
Sarcomeres | 1 | 2013 | 374 | 0.370 |
Why?
|
Exercise Tolerance | 4 | 2018 | 770 | 0.370 |
Why?
|
Data Collection | 3 | 2015 | 3341 | 0.360 |
Why?
|
American Heart Association | 7 | 2023 | 1056 | 0.350 |
Why?
|
Brachiocephalic Trunk | 1 | 2009 | 44 | 0.350 |
Why?
|
Arrhythmias, Cardiac | 5 | 2023 | 2268 | 0.340 |
Why?
|
Patient Compliance | 1 | 2019 | 2684 | 0.330 |
Why?
|
Hypertension, Pulmonary | 2 | 2019 | 1537 | 0.330 |
Why?
|
Delivery, Obstetric | 3 | 2020 | 906 | 0.330 |
Why?
|
Postnatal Care | 3 | 2020 | 236 | 0.320 |
Why?
|
Risk Factors | 36 | 2023 | 72290 | 0.320 |
Why?
|
Vena Cava, Superior | 3 | 2014 | 193 | 0.320 |
Why?
|
Hypertrophy, Right Ventricular | 3 | 2018 | 110 | 0.320 |
Why?
|
Child, Preschool | 27 | 2019 | 41006 | 0.310 |
Why?
|
Coronary Vessels | 3 | 2015 | 3107 | 0.300 |
Why?
|
Pregnancy Outcome | 9 | 2021 | 2795 | 0.300 |
Why?
|
Hematologic Agents | 2 | 2019 | 39 | 0.300 |
Why?
|
Child Welfare | 2 | 2001 | 523 | 0.300 |
Why?
|
Treatment Outcome | 30 | 2023 | 63114 | 0.290 |
Why?
|
Echocardiography, Doppler | 5 | 2018 | 935 | 0.290 |
Why?
|
Vascular Surgical Procedures | 2 | 2013 | 1475 | 0.290 |
Why?
|
Patient Education as Topic | 3 | 2015 | 2278 | 0.290 |
Why?
|
Magnetic Resonance Angiography | 4 | 2015 | 1442 | 0.290 |
Why?
|
Predictive Value of Tests | 20 | 2021 | 15076 | 0.290 |
Why?
|
Male | 89 | 2021 | 350118 | 0.280 |
Why?
|
Coronary Thrombosis | 1 | 2010 | 495 | 0.280 |
Why?
|
Electrocardiography | 7 | 2018 | 6442 | 0.280 |
Why?
|
Stents | 2 | 2015 | 3280 | 0.280 |
Why?
|
Pulmonary Embolism | 2 | 2018 | 2376 | 0.280 |
Why?
|
Retrospective Studies | 43 | 2023 | 77449 | 0.270 |
Why?
|
Heart Diseases | 4 | 2021 | 2788 | 0.270 |
Why?
|
Endocarditis, Bacterial | 2 | 2013 | 455 | 0.270 |
Why?
|
Infant | 23 | 2020 | 35136 | 0.270 |
Why?
|
Heart Transplantation | 5 | 2023 | 3110 | 0.270 |
Why?
|
Follow-Up Studies | 21 | 2019 | 39050 | 0.270 |
Why?
|
Myocardium | 4 | 2018 | 4776 | 0.260 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1392 | 0.260 |
Why?
|
Child | 38 | 2020 | 77709 | 0.260 |
Why?
|
Infant, Newborn | 19 | 2022 | 25625 | 0.250 |
Why?
|
Mentors | 3 | 2019 | 631 | 0.240 |
Why?
|
Tricuspid Atresia | 2 | 2014 | 36 | 0.240 |
Why?
|
Pre-Eclampsia | 1 | 2013 | 1200 | 0.240 |
Why?
|
Risk Adjustment | 2 | 2020 | 594 | 0.240 |
Why?
|
Oxygen | 1 | 2015 | 4189 | 0.240 |
Why?
|
Propensity Score | 2 | 2023 | 1781 | 0.230 |
Why?
|
Survivors | 1 | 2014 | 2291 | 0.230 |
Why?
|
Patient Participation | 1 | 2013 | 1457 | 0.230 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2007 | 478 | 0.230 |
Why?
|
Lower Extremity | 1 | 2011 | 1158 | 0.230 |
Why?
|
Pregnancy Complications | 5 | 2020 | 2861 | 0.220 |
Why?
|
Aorta, Thoracic | 1 | 2009 | 1082 | 0.220 |
Why?
|
Middle Aged | 49 | 2021 | 213383 | 0.220 |
Why?
|
Breast Feeding | 2 | 2023 | 1338 | 0.220 |
Why?
|
Heart Function Tests | 3 | 2019 | 330 | 0.210 |
Why?
|
Cohort Studies | 18 | 2023 | 40561 | 0.210 |
Why?
|
Stroke Volume | 8 | 2021 | 5007 | 0.210 |
Why?
|
Sulfonamides | 1 | 2012 | 1938 | 0.210 |
Why?
|
Ascites | 2 | 2021 | 344 | 0.210 |
Why?
|
Pericarditis | 1 | 2023 | 128 | 0.210 |
Why?
|
Anticoagulants | 2 | 2016 | 4599 | 0.210 |
Why?
|
Liver Transplantation | 2 | 2023 | 2119 | 0.210 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15165 | 0.210 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2019 | 554 | 0.200 |
Why?
|
Exercise | 5 | 2023 | 5615 | 0.200 |
Why?
|
Prospective Studies | 20 | 2023 | 53288 | 0.200 |
Why?
|
Dilatation, Pathologic | 3 | 2019 | 520 | 0.200 |
Why?
|
Blood Pressure | 3 | 2013 | 8554 | 0.200 |
Why?
|
Coronary Vessel Anomalies | 3 | 2016 | 314 | 0.190 |
Why?
|
Time Factors | 17 | 2018 | 40075 | 0.190 |
Why?
|
Tricuspid Valve | 1 | 2023 | 403 | 0.180 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2020 | 63 | 0.180 |
Why?
|
Thrombophilia | 2 | 2020 | 305 | 0.180 |
Why?
|
Hepatic Encephalopathy | 1 | 2021 | 139 | 0.180 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 7279 | 0.180 |
Why?
|
Classification | 1 | 2020 | 129 | 0.180 |
Why?
|
Portugal | 2 | 2016 | 87 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 10 | 2020 | 20129 | 0.180 |
Why?
|
Evidence-Based Medicine | 3 | 2019 | 3610 | 0.180 |
Why?
|
Liver Diseases | 2 | 2023 | 1253 | 0.180 |
Why?
|
Prognosis | 14 | 2018 | 29063 | 0.180 |
Why?
|
Gadolinium | 3 | 2010 | 952 | 0.170 |
Why?
|
Career Choice | 2 | 2017 | 744 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2006 | 851 | 0.170 |
Why?
|
Connective Tissue Diseases | 2 | 2019 | 264 | 0.170 |
Why?
|
Disease Management | 3 | 2019 | 2459 | 0.170 |
Why?
|
Turner Syndrome | 1 | 2020 | 130 | 0.170 |
Why?
|
Bioprosthesis | 2 | 2014 | 596 | 0.170 |
Why?
|
Age Factors | 10 | 2019 | 18370 | 0.170 |
Why?
|
Consensus | 4 | 2021 | 2959 | 0.170 |
Why?
|
Cesarean Section | 4 | 2020 | 1365 | 0.170 |
Why?
|
Prenatal Care | 3 | 2023 | 1092 | 0.170 |
Why?
|
Prevalence | 15 | 2021 | 15226 | 0.160 |
Why?
|
Teratogens | 1 | 2019 | 112 | 0.160 |
Why?
|
Sinus of Valsalva | 2 | 2016 | 59 | 0.160 |
Why?
|
Cross-Sectional Studies | 14 | 2020 | 25043 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3923 | 0.160 |
Why?
|
Breathing Exercises | 1 | 2018 | 53 | 0.160 |
Why?
|
Inhalation | 1 | 2018 | 143 | 0.160 |
Why?
|
Congresses as Topic | 3 | 2018 | 764 | 0.160 |
Why?
|
Respiratory Muscles | 1 | 2018 | 139 | 0.160 |
Why?
|
Risk Assessment | 13 | 2020 | 23338 | 0.160 |
Why?
|
Bacteremia | 1 | 2004 | 962 | 0.150 |
Why?
|
Coronary Angiography | 5 | 2016 | 4577 | 0.150 |
Why?
|
Canada | 2 | 2013 | 2065 | 0.150 |
Why?
|
Private Sector | 1 | 2020 | 392 | 0.150 |
Why?
|
Cause of Death | 3 | 2018 | 3584 | 0.140 |
Why?
|
Arteriosclerosis | 1 | 2001 | 1092 | 0.140 |
Why?
|
Equipment Design | 2 | 2015 | 3582 | 0.140 |
Why?
|
Diabetic Ketoacidosis | 1 | 2020 | 245 | 0.140 |
Why?
|
Anesthetics | 1 | 2022 | 539 | 0.140 |
Why?
|
Hyperlipidemias | 1 | 2001 | 789 | 0.140 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2016 | 314 | 0.140 |
Why?
|
Europe | 2 | 2013 | 3339 | 0.140 |
Why?
|
Stainless Steel | 1 | 2015 | 80 | 0.130 |
Why?
|
Contrast Media | 5 | 2018 | 5300 | 0.130 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5034 | 0.130 |
Why?
|
Observer Variation | 4 | 2020 | 2593 | 0.130 |
Why?
|
Staphylococcal Infections | 1 | 2004 | 1400 | 0.130 |
Why?
|
Standard of Care | 1 | 2019 | 564 | 0.130 |
Why?
|
Cardiac Volume | 2 | 2013 | 210 | 0.130 |
Why?
|
Tooth, Impacted | 1 | 2015 | 42 | 0.130 |
Why?
|
Molar, Third | 1 | 2015 | 49 | 0.130 |
Why?
|
Pacemaker, Artificial | 2 | 2011 | 816 | 0.130 |
Why?
|
Diastole | 2 | 2018 | 791 | 0.120 |
Why?
|
Hospitalization | 5 | 2023 | 10262 | 0.120 |
Why?
|
United States | 17 | 2023 | 69872 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 1107 | 0.120 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2015 | 194 | 0.120 |
Why?
|
Tooth Extraction | 1 | 2015 | 222 | 0.120 |
Why?
|
Galectin 3 | 1 | 2016 | 227 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2001 | 979 | 0.120 |
Why?
|
Multivariate Analysis | 10 | 2018 | 12245 | 0.120 |
Why?
|
Stress, Psychological | 3 | 2024 | 4245 | 0.110 |
Why?
|
Hypertension | 1 | 2013 | 8480 | 0.110 |
Why?
|
Cardiac Care Facilities | 1 | 2013 | 35 | 0.110 |
Why?
|
Death | 1 | 2018 | 678 | 0.110 |
Why?
|
Kidney Calculi | 1 | 1997 | 465 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 711 | 0.110 |
Why?
|
Ventricular Septal Rupture | 1 | 2013 | 18 | 0.110 |
Why?
|
Databases, Factual | 6 | 2021 | 7729 | 0.110 |
Why?
|
Fibrinolytic Agents | 2 | 2020 | 2158 | 0.110 |
Why?
|
Angina Pectoris | 4 | 1993 | 977 | 0.110 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2013 | 66 | 0.110 |
Why?
|
Myocardial Infarction | 4 | 2013 | 11727 | 0.110 |
Why?
|
Hyaluronic Acid | 1 | 2016 | 491 | 0.110 |
Why?
|
Heart Rate | 3 | 2014 | 4091 | 0.110 |
Why?
|
Automation | 1 | 2015 | 584 | 0.110 |
Why?
|
Pediatrics | 3 | 2015 | 3475 | 0.110 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2018 | 574 | 0.110 |
Why?
|
Fetus | 2 | 2016 | 1880 | 0.100 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2012 | 125 | 0.100 |
Why?
|
Patient Selection | 3 | 2020 | 4215 | 0.100 |
Why?
|
Liver | 4 | 2016 | 7474 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1859 | 0.100 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2014 | 493 | 0.100 |
Why?
|
Sarcopenia | 1 | 2016 | 368 | 0.100 |
Why?
|
Spinal Cord | 2 | 1999 | 1809 | 0.100 |
Why?
|
Astrocytes | 1 | 1999 | 1270 | 0.100 |
Why?
|
Anesthesia | 1 | 2022 | 1561 | 0.100 |
Why?
|
Hemorrhage | 2 | 2020 | 3461 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2016 | 3327 | 0.100 |
Why?
|
Women's Health | 1 | 2020 | 2034 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2014 | 441 | 0.100 |
Why?
|
Pulmonary Circulation | 4 | 2018 | 739 | 0.100 |
Why?
|
Radiation Dosage | 1 | 2019 | 1928 | 0.090 |
Why?
|
Hospital Costs | 1 | 2017 | 985 | 0.090 |
Why?
|
Advisory Committees | 1 | 2015 | 775 | 0.090 |
Why?
|
Multicenter Studies as Topic | 2 | 2022 | 1677 | 0.090 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6487 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1181 | 0.090 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 250 | 0.090 |
Why?
|
Critical Care | 1 | 2023 | 2647 | 0.090 |
Why?
|
Disease Progression | 6 | 2018 | 13284 | 0.090 |
Why?
|
Electric Countershock | 1 | 2013 | 534 | 0.090 |
Why?
|
Heart Block | 1 | 2011 | 410 | 0.090 |
Why?
|
Heart Septum | 1 | 2010 | 313 | 0.090 |
Why?
|
Survival Analysis | 4 | 2018 | 10252 | 0.090 |
Why?
|
Italy | 3 | 2021 | 832 | 0.090 |
Why?
|
Elasticity Imaging Techniques | 1 | 2014 | 388 | 0.080 |
Why?
|
Pilot Projects | 3 | 2023 | 8324 | 0.080 |
Why?
|
End Stage Liver Disease | 1 | 2013 | 314 | 0.080 |
Why?
|
Dobutamine | 1 | 2009 | 123 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.080 |
Why?
|
Radiography | 5 | 2013 | 7023 | 0.080 |
Why?
|
Chronic Disease | 2 | 2016 | 9146 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2015 | 1198 | 0.080 |
Why?
|
Acute Disease | 2 | 2016 | 7149 | 0.080 |
Why?
|
Biomedical Research | 3 | 2018 | 3309 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1265 | 0.080 |
Why?
|
ROC Curve | 4 | 2018 | 3527 | 0.080 |
Why?
|
Insurance, Health | 1 | 2020 | 2494 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2001 | 3864 | 0.080 |
Why?
|
Ventricular Function | 1 | 2009 | 416 | 0.080 |
Why?
|
Postoperative Period | 1 | 2012 | 1842 | 0.080 |
Why?
|
Prosthesis-Related Infections | 1 | 2013 | 538 | 0.070 |
Why?
|
Preoperative Care | 2 | 2015 | 2250 | 0.070 |
Why?
|
Pulmonary Veins | 1 | 2013 | 761 | 0.070 |
Why?
|
Cardiomyopathies | 2 | 2019 | 1912 | 0.070 |
Why?
|
Heart | 3 | 2020 | 4467 | 0.070 |
Why?
|
Education, Medical | 1 | 2019 | 1721 | 0.070 |
Why?
|
Osteoporosis | 1 | 2016 | 1580 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2968 | 0.070 |
Why?
|
Electrodes, Implanted | 1 | 2011 | 824 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3778 | 0.070 |
Why?
|
Aortic Diseases | 1 | 2012 | 742 | 0.070 |
Why?
|
Fibrosis | 3 | 2018 | 2029 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2012 | 996 | 0.070 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15540 | 0.070 |
Why?
|
Heterozygote | 1 | 2013 | 2804 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2015 | 1076 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2013 | 12959 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3760 | 0.070 |
Why?
|
Reoperation | 4 | 2020 | 4201 | 0.070 |
Why?
|
Calcinosis | 1 | 2015 | 1499 | 0.070 |
Why?
|
Depression | 2 | 2024 | 7766 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2013 | 1049 | 0.070 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 535 | 0.070 |
Why?
|
Physicians | 2 | 2014 | 4567 | 0.070 |
Why?
|
Stem Cells | 1 | 1999 | 3567 | 0.070 |
Why?
|
Angiography | 3 | 2020 | 1639 | 0.070 |
Why?
|
Anesthesia, Obstetrical | 1 | 2008 | 235 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 3 | 2015 | 4042 | 0.070 |
Why?
|
Aged | 16 | 2021 | 163280 | 0.060 |
Why?
|
Leg | 1 | 2010 | 1116 | 0.060 |
Why?
|
Liver Function Tests | 2 | 2016 | 528 | 0.060 |
Why?
|
Aorta | 1 | 2012 | 2061 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 822 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1541 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1142 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Dyspnea | 1 | 2012 | 1303 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.060 |
Why?
|
Defibrillators, Implantable | 1 | 2013 | 1440 | 0.060 |
Why?
|
Sex Factors | 4 | 2020 | 10397 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2759 | 0.060 |
Why?
|
Intracranial Aneurysm | 1 | 2012 | 1197 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6234 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2013 | 2057 | 0.060 |
Why?
|
Algorithms | 3 | 2019 | 13881 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 2012 | 2731 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 243 | 0.050 |
Why?
|
Area Under Curve | 2 | 2018 | 1654 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 1 | 2012 | 1422 | 0.050 |
Why?
|
Aftercare | 2 | 2020 | 866 | 0.050 |
Why?
|
Prone Position | 1 | 2003 | 194 | 0.050 |
Why?
|
Heart-Assist Devices | 1 | 2012 | 1194 | 0.050 |
Why?
|
Image Enhancement | 2 | 2015 | 2921 | 0.050 |
Why?
|
Erysipelas | 1 | 2000 | 2 | 0.050 |
Why?
|
Adolescent Medicine | 1 | 2001 | 72 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1239 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2758 | 0.050 |
Why?
|
Survival Rate | 5 | 2020 | 12788 | 0.050 |
Why?
|
Gestational Age | 3 | 2020 | 3493 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2008 | 1171 | 0.050 |
Why?
|
Linear Models | 3 | 2016 | 5952 | 0.050 |
Why?
|
Incidence | 5 | 2021 | 20947 | 0.050 |
Why?
|
Pulmonary Atresia | 2 | 2012 | 160 | 0.050 |
Why?
|
Diet Therapy | 1 | 2001 | 154 | 0.050 |
Why?
|
Health Status | 1 | 2013 | 4034 | 0.050 |
Why?
|
Reference Values | 3 | 2015 | 4982 | 0.050 |
Why?
|
Logistic Models | 4 | 2018 | 13408 | 0.050 |
Why?
|
Educational Measurement | 2 | 2019 | 1210 | 0.040 |
Why?
|
Radionuclide Imaging | 3 | 2009 | 2031 | 0.040 |
Why?
|
Sudden Infant Death | 1 | 2003 | 291 | 0.040 |
Why?
|
Internship and Residency | 2 | 2015 | 5788 | 0.040 |
Why?
|
Extraction, Obstetrical | 1 | 2019 | 26 | 0.040 |
Why?
|
Obesity | 2 | 2001 | 12745 | 0.040 |
Why?
|
Piperidines | 1 | 2008 | 1602 | 0.040 |
Why?
|
Valsalva Maneuver | 1 | 2019 | 92 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1999 | 1801 | 0.040 |
Why?
|
Heart Atria | 2 | 2018 | 1357 | 0.040 |
Why?
|
Inspiratory Capacity | 1 | 2018 | 36 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 2886 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2011 | 2104 | 0.040 |
Why?
|
Trout | 1 | 1998 | 18 | 0.040 |
Why?
|
Carps | 1 | 1998 | 52 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1869 | 0.040 |
Why?
|
Chemoprevention | 1 | 2020 | 319 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4468 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6196 | 0.040 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 1999 | 140 | 0.040 |
Why?
|
Boston | 3 | 2018 | 9313 | 0.040 |
Why?
|
Cryptorchidism | 1 | 1998 | 125 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1769 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1999 | 528 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2002 | 658 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57776 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2013 | 13989 | 0.040 |
Why?
|
Chick Embryo | 1 | 1999 | 982 | 0.040 |
Why?
|
Postmenopause | 1 | 2006 | 2461 | 0.040 |
Why?
|
Chickens | 1 | 1999 | 865 | 0.040 |
Why?
|
Kentucky | 1 | 2016 | 83 | 0.040 |
Why?
|
New England | 1 | 2019 | 1022 | 0.040 |
Why?
|
Ureteroscopy | 1 | 1997 | 142 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2004 | 1451 | 0.040 |
Why?
|
Neurofilament Proteins | 1 | 1998 | 318 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 5987 | 0.030 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2015 | 31 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11725 | 0.030 |
Why?
|
Prosthesis Design | 2 | 2013 | 2110 | 0.030 |
Why?
|
Japan | 1 | 2020 | 1360 | 0.030 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 258 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11366 | 0.030 |
Why?
|
Proteomics | 1 | 2009 | 3638 | 0.030 |
Why?
|
Body Mass Index | 3 | 2016 | 12720 | 0.030 |
Why?
|
Fatigue | 1 | 2002 | 1531 | 0.030 |
Why?
|
Biopsy | 3 | 2016 | 6756 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2018 | 620 | 0.030 |
Why?
|
Dehydration | 1 | 2016 | 234 | 0.030 |
Why?
|
Anesthesia, Dental | 1 | 2015 | 67 | 0.030 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2015 | 50 | 0.030 |
Why?
|
Treatment Failure | 2 | 2012 | 2618 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2009 | 1590 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2014 | 585 | 0.030 |
Why?
|
Spermatozoa | 1 | 1998 | 625 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 956 | 0.030 |
Why?
|
Abruptio Placentae | 1 | 2015 | 118 | 0.030 |
Why?
|
Species Specificity | 1 | 1999 | 2478 | 0.030 |
Why?
|
Recurrence | 2 | 2023 | 8340 | 0.030 |
Why?
|
Hepatitis, Alcoholic | 1 | 1996 | 103 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.030 |
Why?
|
Clinical Coding | 1 | 2015 | 171 | 0.030 |
Why?
|
Meglumine | 1 | 2014 | 149 | 0.030 |
Why?
|
Hepatitis | 1 | 1996 | 227 | 0.030 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 173 | 0.030 |
Why?
|
Lymphedema | 1 | 2000 | 534 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2015 | 19905 | 0.030 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2014 | 143 | 0.030 |
Why?
|
Competency-Based Education | 1 | 2015 | 211 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2015 | 456 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2017 | 705 | 0.030 |
Why?
|
Galectins | 1 | 2016 | 268 | 0.030 |
Why?
|
Smoking | 1 | 2010 | 8987 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 3507 | 0.030 |
Why?
|
Infant, Premature, Diseases | 1 | 1999 | 706 | 0.030 |
Why?
|
Thinness | 1 | 2016 | 480 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2645 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 725 | 0.030 |
Why?
|
Patient Advocacy | 1 | 2015 | 353 | 0.030 |
Why?
|
Electric Impedance | 1 | 2016 | 729 | 0.030 |
Why?
|
Coronary Disease | 3 | 1992 | 6077 | 0.030 |
Why?
|
Venous Pressure | 1 | 2012 | 56 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2015 | 836 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6538 | 0.030 |
Why?
|
Ohio | 1 | 2012 | 337 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2020 | 1695 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2019 | 2453 | 0.030 |
Why?
|
Language | 1 | 2021 | 1471 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3508 | 0.030 |
Why?
|
History, 21st Century | 1 | 2018 | 1534 | 0.030 |
Why?
|
Inpatients | 1 | 2023 | 2518 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 841 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2008 | 3674 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 570 | 0.030 |
Why?
|
Odds Ratio | 2 | 2015 | 9849 | 0.030 |
Why?
|
Aspirin | 1 | 2023 | 3282 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2014 | 1681 | 0.020 |
Why?
|
Ultrasonography | 3 | 2013 | 5985 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 987 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1107 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1686 | 0.020 |
Why?
|
Bilirubin | 1 | 2013 | 425 | 0.020 |
Why?
|
Sternotomy | 1 | 2012 | 121 | 0.020 |
Why?
|
Autopsy | 1 | 2015 | 1020 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1525 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 1997 | 780 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1641 | 0.020 |
Why?
|
Massachusetts | 2 | 2015 | 8663 | 0.020 |
Why?
|
Liver Circulation | 1 | 2011 | 164 | 0.020 |
Why?
|
Blood Proteins | 1 | 2016 | 1124 | 0.020 |
Why?
|
Isosorbide Dinitrate | 1 | 1990 | 34 | 0.020 |
Why?
|
Netherlands | 1 | 2015 | 2170 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1637 | 0.020 |
Why?
|
Skull Fractures | 1 | 1992 | 195 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2951 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2014 | 665 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14722 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2252 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 1993 | 514 | 0.020 |
Why?
|
Autoantibodies | 1 | 1998 | 2035 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2002 | 2291 | 0.020 |
Why?
|
Nifedipine | 1 | 1990 | 226 | 0.020 |
Why?
|
Axons | 1 | 1998 | 1684 | 0.020 |
Why?
|
Weight Loss | 1 | 2001 | 2622 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8949 | 0.020 |
Why?
|
Fatty Liver | 1 | 1996 | 727 | 0.020 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 137 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
Protein-Losing Enteropathies | 1 | 2009 | 45 | 0.020 |
Why?
|
Goals | 1 | 2015 | 706 | 0.020 |
Why?
|
Thoracotomy | 1 | 2011 | 363 | 0.020 |
Why?
|
Leadership | 1 | 2019 | 1357 | 0.020 |
Why?
|
Collateral Circulation | 1 | 1990 | 287 | 0.020 |
Why?
|
Clinical Competence | 2 | 2015 | 4687 | 0.020 |
Why?
|
Cerebellar Neoplasms | 1 | 1994 | 587 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2012 | 936 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 279 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1184 | 0.020 |
Why?
|
Bronchitis | 1 | 2009 | 201 | 0.020 |
Why?
|
Medulloblastoma | 1 | 1994 | 683 | 0.020 |
Why?
|
Ventricular Dysfunction | 1 | 2009 | 143 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29786 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 2012 | 579 | 0.020 |
Why?
|
Materials Testing | 1 | 2012 | 867 | 0.020 |
Why?
|
Comorbidity | 2 | 2015 | 10388 | 0.020 |
Why?
|
Atrial Flutter | 1 | 2010 | 263 | 0.020 |
Why?
|
Ligation | 1 | 2009 | 453 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2925 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1184 | 0.020 |
Why?
|
Health Care Costs | 1 | 2021 | 3209 | 0.020 |
Why?
|
Angina, Unstable | 1 | 1992 | 926 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1827 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 2013 | 688 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 21746 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 2682 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 1919 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1174 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1285 | 0.020 |
Why?
|
Body Composition | 1 | 2016 | 2401 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1993 | 1572 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2008 | 383 | 0.020 |
Why?
|
Pericardium | 1 | 2011 | 667 | 0.020 |
Why?
|
Syndrome | 1 | 1993 | 3251 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3528 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4217 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2008 | 648 | 0.020 |
Why?
|
Quality of Life | 2 | 2020 | 12804 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 1990 | 793 | 0.020 |
Why?
|
Tissue and Organ Harvesting | 1 | 2009 | 369 | 0.020 |
Why?
|
Mass Screening | 1 | 2001 | 5255 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2012 | 1133 | 0.020 |
Why?
|
Body Weight | 1 | 2016 | 4669 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2001 | 7913 | 0.020 |
Why?
|
Norepinephrine | 1 | 2008 | 909 | 0.020 |
Why?
|
Growth Hormone | 1 | 2008 | 705 | 0.020 |
Why?
|
Motion | 1 | 2009 | 798 | 0.020 |
Why?
|
Chest Pain | 1 | 2012 | 1114 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2012 | 1257 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 1999 | 9274 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.020 |
Why?
|
Epinephrine | 1 | 2008 | 792 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3271 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2429 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6309 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2013 | 1775 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5317 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2009 | 804 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2009 | 2726 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2505 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 3068 | 0.010 |
Why?
|
Supine Position | 1 | 2003 | 205 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2012 | 2266 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1985 | 544 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3605 | 0.010 |
Why?
|
Patient Readmission | 1 | 2016 | 3114 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5756 | 0.010 |
Why?
|
Sampling Studies | 1 | 2003 | 623 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12354 | 0.010 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2000 | 66 | 0.010 |
Why?
|
Antimony | 1 | 2000 | 19 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4931 | 0.010 |
Why?
|
Animals | 4 | 2018 | 168757 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2015 | 4043 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9687 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2008 | 1403 | 0.010 |
Why?
|
Brain Injuries | 1 | 1992 | 2025 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2014 | 4371 | 0.010 |
Why?
|
Amniocentesis | 1 | 1999 | 116 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5078 | 0.010 |
Why?
|
Swine | 1 | 2009 | 5917 | 0.010 |
Why?
|
Long QT Syndrome | 1 | 2003 | 453 | 0.010 |
Why?
|
Work Schedule Tolerance | 1 | 2002 | 565 | 0.010 |
Why?
|
Dilatation and Curettage | 1 | 1997 | 56 | 0.010 |
Why?
|
Heart Conduction System | 1 | 2003 | 1047 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.010 |
Why?
|
Cross Reactions | 1 | 1998 | 841 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1999 | 732 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1994 | 9239 | 0.010 |
Why?
|
Obstetric Labor Complications | 1 | 1997 | 238 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2003 | 1738 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7181 | 0.010 |
Why?
|
Maternal Mortality | 1 | 1997 | 310 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2645 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 6103 | 0.010 |
Why?
|
Cranial Fossa, Posterior | 1 | 1994 | 139 | 0.010 |
Why?
|
Mammals | 1 | 1998 | 1143 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1992 | 378 | 0.010 |
Why?
|
Postoperative Care | 1 | 1998 | 1486 | 0.010 |
Why?
|
Abortion, Induced | 1 | 1997 | 458 | 0.010 |
Why?
|
Epitopes | 1 | 1998 | 2571 | 0.010 |
Why?
|
Emergencies | 1 | 1997 | 1170 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 12072 | 0.010 |
Why?
|
Blotting, Western | 1 | 1998 | 5179 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 1992 | 570 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18029 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 1997 | 1199 | 0.010 |
Why?
|
Diabetes Complications | 1 | 1996 | 1359 | 0.010 |
Why?
|
Coma | 1 | 1992 | 475 | 0.000 |
Why?
|
Phosphorylation | 1 | 1998 | 8436 | 0.000 |
Why?
|
Schizophrenia | 1 | 1985 | 6882 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1996 | 2708 | 0.000 |
Why?
|
Wechsler Scales | 1 | 1985 | 260 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1994 | 8642 | 0.000 |
Why?
|
Intelligence | 1 | 1985 | 920 | 0.000 |
Why?
|
Schizophrenic Psychology | 1 | 1985 | 1678 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 1985 | 6993 | 0.000 |
Why?
|
Brain | 1 | 1992 | 26385 | 0.000 |
Why?
|